Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling

Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer and is characterized by high rates of metastasis. Cancer stem cell is a vital cause of renal cancer metastasis and recurrence. However, little is known regarding the change and the roles of stem cells during the devel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hongzhi Wang, Hanjiang Xu, Quan Cheng, Chaozhao Liang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/53cfec79e44749ffbe5b62c90f6efe01
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:53cfec79e44749ffbe5b62c90f6efe01
record_format dspace
spelling oai:doaj.org-article:53cfec79e44749ffbe5b62c90f6efe012021-12-01T13:58:27ZIdentification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling2234-943X10.3389/fonc.2021.758989https://doaj.org/article/53cfec79e44749ffbe5b62c90f6efe012021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.758989/fullhttps://doaj.org/toc/2234-943XClear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer and is characterized by high rates of metastasis. Cancer stem cell is a vital cause of renal cancer metastasis and recurrence. However, little is known regarding the change and the roles of stem cells during the development of renal cancer. To clarify this problem, we developed a novel stem cell clustering strategy. Based on The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) genomic datasets, we used 19 stem cell gene sets to classify each dataset. A machine learning method was used to perform the classification. We classified ccRCC into three subtypes—stem cell activated (SC-A), stem cell dormant (SC-D), and stem cell excluded (SC-E)—based on the expressions of stem cell-related genes. Compared with the other subtypes, C2(SC-A) had the highest degree of cancer stem cell concentration, the highest level of immune cell infiltration, a distinct mutation landscape, and the worst prognosis. Moreover, drug sensitivity analysis revealed that subgroup C2(SC-A) had the highest sensitivity to immunotherapy CTLA-4 blockade and the vascular endothelial growth factor receptor (VEGFR) inhibitor sunitinib. The identification of ccRCC subtypes based on cancer stem cell gene sets demonstrated the heterogeneity of ccRCC and provided a new strategy for its treatment.Hongzhi WangHongzhi WangHongzhi WangHanjiang XuHanjiang XuHanjiang XuQuan ChengChaozhao LiangChaozhao LiangChaozhao LiangFrontiers Media S.A.articleclear cell renal cell cancer (ccRCC)stem cellsubtypegene expressionimmune microenvironmentNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic clear cell renal cell cancer (ccRCC)
stem cell
subtype
gene expression
immune microenvironment
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle clear cell renal cell cancer (ccRCC)
stem cell
subtype
gene expression
immune microenvironment
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Hongzhi Wang
Hongzhi Wang
Hongzhi Wang
Hanjiang Xu
Hanjiang Xu
Hanjiang Xu
Quan Cheng
Chaozhao Liang
Chaozhao Liang
Chaozhao Liang
Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
description Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer and is characterized by high rates of metastasis. Cancer stem cell is a vital cause of renal cancer metastasis and recurrence. However, little is known regarding the change and the roles of stem cells during the development of renal cancer. To clarify this problem, we developed a novel stem cell clustering strategy. Based on The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) genomic datasets, we used 19 stem cell gene sets to classify each dataset. A machine learning method was used to perform the classification. We classified ccRCC into three subtypes—stem cell activated (SC-A), stem cell dormant (SC-D), and stem cell excluded (SC-E)—based on the expressions of stem cell-related genes. Compared with the other subtypes, C2(SC-A) had the highest degree of cancer stem cell concentration, the highest level of immune cell infiltration, a distinct mutation landscape, and the worst prognosis. Moreover, drug sensitivity analysis revealed that subgroup C2(SC-A) had the highest sensitivity to immunotherapy CTLA-4 blockade and the vascular endothelial growth factor receptor (VEGFR) inhibitor sunitinib. The identification of ccRCC subtypes based on cancer stem cell gene sets demonstrated the heterogeneity of ccRCC and provided a new strategy for its treatment.
format article
author Hongzhi Wang
Hongzhi Wang
Hongzhi Wang
Hanjiang Xu
Hanjiang Xu
Hanjiang Xu
Quan Cheng
Chaozhao Liang
Chaozhao Liang
Chaozhao Liang
author_facet Hongzhi Wang
Hongzhi Wang
Hongzhi Wang
Hanjiang Xu
Hanjiang Xu
Hanjiang Xu
Quan Cheng
Chaozhao Liang
Chaozhao Liang
Chaozhao Liang
author_sort Hongzhi Wang
title Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
title_short Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
title_full Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
title_fullStr Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
title_full_unstemmed Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
title_sort identification of a novel stem cell subtype for clear cell renal cell carcinoma based on stem cell gene profiling
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/53cfec79e44749ffbe5b62c90f6efe01
work_keys_str_mv AT hongzhiwang identificationofanovelstemcellsubtypeforclearcellrenalcellcarcinomabasedonstemcellgeneprofiling
AT hongzhiwang identificationofanovelstemcellsubtypeforclearcellrenalcellcarcinomabasedonstemcellgeneprofiling
AT hongzhiwang identificationofanovelstemcellsubtypeforclearcellrenalcellcarcinomabasedonstemcellgeneprofiling
AT hanjiangxu identificationofanovelstemcellsubtypeforclearcellrenalcellcarcinomabasedonstemcellgeneprofiling
AT hanjiangxu identificationofanovelstemcellsubtypeforclearcellrenalcellcarcinomabasedonstemcellgeneprofiling
AT hanjiangxu identificationofanovelstemcellsubtypeforclearcellrenalcellcarcinomabasedonstemcellgeneprofiling
AT quancheng identificationofanovelstemcellsubtypeforclearcellrenalcellcarcinomabasedonstemcellgeneprofiling
AT chaozhaoliang identificationofanovelstemcellsubtypeforclearcellrenalcellcarcinomabasedonstemcellgeneprofiling
AT chaozhaoliang identificationofanovelstemcellsubtypeforclearcellrenalcellcarcinomabasedonstemcellgeneprofiling
AT chaozhaoliang identificationofanovelstemcellsubtypeforclearcellrenalcellcarcinomabasedonstemcellgeneprofiling
_version_ 1718405058105704448